Found: 14
Select item for more details and to access through your institution.
Single- and multiple-dose pharmacokinetics of oral dolasetron and its active metabolites in healthy volunteers: part 2.
- Published in:
- Biopharmaceutics & Drug Disposition, 1999, v. 20, n. 1, p. 41, doi. 10.1002/(SICI)1099-081X(199901)20:1<41::AID-BDD150>3.0.CO;2-G
- By:
- Publication type:
- Article
Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.
- Published in:
- Biopharmaceutics & Drug Disposition, 1999, v. 20, n. 1, p. 29, doi. 10.1002/(SICI)1099-081X(199901)20:1<29::AID-BDD151>3.0.CO;2-S
- By:
- Publication type:
- Article
The effect of food on the bioavailability of dolasetron mesylate tablets.
- Published in:
- Biopharmaceutics & Drug Disposition, 1998, v. 19, n. 1, p. 17, doi. 10.1002/(SICI)1099-081X(199801)19:1<17::AID-BDD71>3.0.CO;2-#
- By:
- Publication type:
- Article
Pharmacokinetics of dolasetron following single- and multiple-dose intravenous administration to normal male subjects.
- Published in:
- Biopharmaceutics & Drug Disposition, 1995, v. 16, n. 3, p. 177, doi. 10.1002/bdd.2510160303
- By:
- Publication type:
- Article
Human dolasetron pharmacokinetics: II Absorption and disposition following single-dose oral administration to normal male subjects.
- Published in:
- Biopharmaceutics & Drug Disposition, 1993, v. 14, n. 2, p. 131, doi. 10.1002/bdd.2510140205
- By:
- Publication type:
- Article
Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjects.
- Published in:
- Biopharmaceutics & Drug Disposition, 1992, v. 13, n. 9, p. 693, doi. 10.1002/bdd.2510130907
- By:
- Publication type:
- Article
Multiple‐Dose, Placebo‐Controlled, Phase I Study of Oral Dolasetron.
- Published in:
- Pharmacotherapy, 1996, v. 16, n. 2, p. 253, doi. 10.1002/j.1875-9114.1996.tb02942.x
- By:
- Publication type:
- Article
Single‐Dose, Placebo‐Controlled, Phase I Study of Oral Dolasetron.
- Published in:
- Pharmacotherapy, 1996, v. 16, n. 2, p. 245, doi. 10.1002/j.1875-9114.1996.tb02941.x
- By:
- Publication type:
- Article
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy.
- Published in:
- Cancer (0008543X), 1997, v. 79, n. 6, p. 1216, doi. 10.1002/(SICI)1097-0142(19970315)79:6<1216::AID-CNCR22>3.0.CO;2-1
- By:
- Publication type:
- Article
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 3, p. 423, doi. 10.1007/s00280-007-0490-z
- By:
- Publication type:
- Article
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 58, p. 41, doi. 10.1111/j.1365-2125.2004.01799.x
- By:
- Publication type:
- Article
Pharmacokinetics of Dolasetron after Oral and Intravenous Administration of Dolasetron Mesylate in Healthy Volunteers and Patients with Hepatic Dysfunction.
- Published in:
- 1997
- By:
- Publication type:
- Other
A Double-Blind, Placebo-Controlled, Dose-Ranging Safety Evaluation of Single-Dose Intravenous Dolasetron in Healthy Male Volunteers.
- Published in:
- 1995
- By:
- Publication type:
- Other